LOZMAX - 600

LOZMAX 600 DISCRIPTION: 84% SUCCESS RATE IN MRSA COMPLICATED SKIN AND SKIN STRUTURE INFECTION THAN 80% WITH VANCOMYCIN. OFFERS ESTABLISHED EFFICACY IN NOSOCOMIAL PNEUMONIA (NP), INCLUED VENTILATOR ASSOCAITED PNEUMONIA (VAP) DUE TO MRSA. CONCENTRATION IN EPITHELIAL LINIG FLUID IS 2 TOT 4 TIMES GREATER THAN THAT FOUND IN PLASMA THROUGHOUT THE DOSING INTERVAL. PENETRATES PULMONARYY EPITHELIAL LINIG FLUID IN CRITICALLY ILL PATIENTS WITH VENTILATOR ASSOCIATED PNEUMONIA (VAP). INDICATION: COMPICATED SKIN AND SKIN STRUCUTRE INFECTION DIABETIC FOOT INFECTION